Stay updated on Pediatric Tolerability of Xerecept in Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.

Latest updates to the Pediatric Tolerability of Xerecept in Clinical Trial page
- Check4 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no study content or page functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA consolidated Locations section now lists Illinois and Massachusetts as study sites, replacing separate 'Illinois Locations' and 'Massachusetts Locations' entries. The HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.SummaryDifference0.4%

- Check54 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous v3.2.0.SummaryDifference0.1%

- Check61 days agoChange DetectedDeleted administrative notice about government funding and operating status. Study details, contacts, and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check75 days agoChange DetectedUpdates to the Study Details page include revised eligibility criteria, primary completion date, and study design details.SummaryDifference0.4%

- Check104 days agoChange DetectedCore content updated to reflect current operating status and a new version (v3.2.0) while removing the old version label (v3.1.0).SummaryDifference5%

Stay in the know with updates to Pediatric Tolerability of Xerecept in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.